Bio-science companies rely more heavily on having an effective intellectual property portfolio than do companies based on other technologies. This workshop will cover basic elements involved in developing a commercially meaningful intellectual property portfolio for a bio-science company. Topics that will be discussed include identifying and protecting bio-science inventions, as well as decision making in developing, managing and investing in the portfolio.
This workshop is reserved for Founders, CEO’s, Entrepreneurs, Managers, Researchers, VCs, Business Development Professionals, and Scientists, ONLY. Please, no competing law firms or private competitors.
8:00am - 8:30am: Registration & Light Breakfast
8:30am - 11:30am: Program
11:30am - 12:00 pm: Lunch (optional)
John Wetherell, J.D., PhD. has over 25 years’ experience in intellectual property law. His counseling experience includes intellectual property acquisition, transactional due diligence, patent infringement and validity analyses, freedom-to-operate opinions, as well as licensing and strategic counseling. Dr. Wetherell’s patent prosecution experience includes obtaining U.S. and foreign protection in biotechnology areas such as molecular biology, immunology, nanotechnology, medical diagnostics, microbiology and pharmacology. He also evaluates intellectual property portfolios for both companies and investors. At Pillsbury, Dr. Wetherell is the partner in charge of the Intellectual Property practice group in the San Diego office, co-leader of the National Life Science industry group, leader of the Stem Cell Outlook and Planning Effort (SCOPE), and a member of the Clean Technology Group.